Farther Finance Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History

Farther Finance Advisors’s Portfolio AMLX Stock Details AMLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.65K	Buy	259 +237	+1,077%	+$3.67K	﹤0.01%	4838
2026 Q1	$316	Buy	22 +2	+10%	+$28	﹤0.01%	5362
2025 Q4	$242	Hold	20	–	–	﹤0.01%	5184
2025 Q3	$272	Buy	+20	New	+$188	﹤0.01%	4661
2024 Q1	–	Sell	-27	Closed	-$397	–	3591
2023 Q4	$397	Buy	+27	New	+$414	﹤0.01%	3048

Other funds holding AMLX

MAP

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

PPWP

Premier Path Wealth Partners Madison, New Jersey $870M AUM 30% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Farther Finance Advisors's AMLX Position: Q2 2026 in Review

Farther Finance Advisors increased its Amylyx Pharmaceuticals (AMLX) stake by 1,077% in Q2 2026, buying an estimated $3.67K and bringing the position to 259 shares worth $4.65K. The position accounts for ﹤0.01% of the portfolio, ranked #4838.

Farther Finance Advisors first reported a position in AMLX in Q4 2023 and has held it in 5 quarters since. 17 funds tracked by Wall St. Rank hold AMLX as of Q2 2026.

Farther Finance Advisors held 259 shares of Amylyx Pharmaceuticals worth $4.65K as of Q2 2026.
Farther Finance Advisors bought 237 Amylyx Pharmaceuticals shares in Q2 2026, an estimated $3.67K.
Amylyx Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #4838 holding.
Farther Finance Advisors first reported a position in Amylyx Pharmaceuticals in Q4 2023 and has held it in 5 quarters since.
17 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.